References
- Gormley ME Jr, O'Brien CF, Yablon SA. A clinical overview of treatment decisions in the management of spasticity. Muscle Nerve Suppl 1997;6:S14–20.
- Lance J. Pathophysiology of spasticity and clinical experience with baclofen. In: Feldman R, Young R, Koella W, editors. Spasticity: Disordered Motor Control. Chicago, IL: Year Book Medical Publishers; 1980. pp. 185–203.
- Gracies JM, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity: Part I: Local treat-ments. Muscle Nerve Suppl 1997;6:S61–91.
- Gracies JM, Nance P, Elovic E, McGuire J, Simpson D. Traditional pharmacological treatments for spasticity: Part II: General and regional treatments. Muscle Nerve Suppl 1997;6:S92–121.
- Simpson DM. Clinical trials of botulinum toxin in the treatment of spasticity. Muscle Nerve Suppl 1997;6:5169–75.
- Gudex CM, Hawthorne MR, Butler AG, Duffey P. Effect of dystonia and botulinum toxin treatment on health-Related quality of life. Movement Disorders 1998;13:941–6.
- Molenaers G, Desloovere K, Eyssen M, De Cat J, Jonkers I, De Cock P. Botulinum toxin Type A treatment of cerebral palsy: An integrated approach. European Journal of Neurology 1999; 6 (suppl 4):551–7.
- Van Kuijk A, Geurts A, Bevaart B, Van Limbeek J. Treatment of upper extremity spasticity in stroke patients by focal neuron or neuromuscular blockade: A systematic review of literature. Journal of Rehabilitation Medicine 2002;34:51–61.
- Boyd R, Morris M, Graham H. Management of upper limb dysfunction in children with cerebral palsy: A systematic review. European Journal of Neurology 2001;8(Suppl 5):150–66.
- Fehlings D, Rang M, Glazier J. Botulinum toxin type A injections in the spastic upper extremity of child with hemiplegia: Child characteristics that predict a positive out-come. European Journal of Neurology 2001;8(Suppl 5): 145–9.
- Cosgrove AP, Corry IS, Graham HK. Botulinum toxin in the management of the lower limb in cerebral palsy. Developmental Medicine and Child Neurology 1994;36:386–96.
- Yablon SA, Agana BT, Ivanhoe CB, Boake C. Botulinum toxin in severe upper extremity spasticity among patients with traumatic brain injury: An open-labeled trial. Neurology 1996;47:939–44.
- Autti-Ramo I, Larsen A, Taimo A, von Wendt L. Management of the upper limb with botulinum toxin type A in children with spastic type cerebral palsy and acquired brain injury: Clinical implications. European Journal of Neurology 2001;8(Suppl 5):5136–44.
- Brashear A, Gordon M, Elovic E, Kassicieh VD, Marciniak C, Do M, Lee CH, Jenkins S, Turkel C; Botox Post Stroke Spasticity Study Group. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. New England Journal of Medicine 2002;347:395–400.
- Brashear A, McAfee AL, Kuhn ER, Fyffe J. Botulinum toxin type B in upper limb poststroke spasticity: A double-blind, placebo-controlled trial. Archives of Physical Medicine and Rehabilitation 2004;85:705–9.
- Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Local botulinum toxin in the treatment of spastic foot drop. Journal of Neurology 1992;239:375–8.
- Molenaers G, Desloovere K, Jonkers I, Glorieux F, De Cock P. The effect of multilevel botulinum toxin type A treatment combined with short leg casting and orthotic management on the gait of CP children. Gait Posture 1999;10:74.
- Burbaud P, Wiart L, Dubos JL, Gaujard E, Debelleix X, Joseph PA, Mazaux JM, Bioulac B, Barat M, Lagueny A. A randomised, double-blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. Journal of Neurology, Neurosurgery and Psychiatry 1996;61:265–9.